The global Recombinant Proteins market size was valued at USD 740.2 million in 2022 and is forecast to a readjusted size of USD 1248.3 million by 2029 with a CAGR of 7.8% during review period.
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Abcam PLC was the largest company in the global Recombinant Proteins market, with a revenue market share of 13% in 2018. Top 5 companies occupied 40% of the market. By region, Europe was the biggest region, with a revenue market share over 33%, and North America ranked 2. Asia-Pacific ranked 3, and its market grew fastest.
This report is a detailed and comprehensive analysis for global Recombinant Proteins market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Recombinant Proteins market size and forecasts, in consumption value ($ Million), 2018-2029
Global Recombinant Proteins market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Recombinant Proteins market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Recombinant Proteins market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Proteins
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Proteins market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Abcam PLC
R&D Systems
Miltenyi Biotec
Thermo Fisher Scientific
Sigma Aldrich Company
GE Healthcare
Lonza
Merck KGaA
ProSpec Tany TechnoGene
Eurogentec (Kaneka Corporation)
PeproTech
BPS Bioscience
Reprocell
GenScript Biotech Corporation
Abnova Corporation
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Recombinant Proteins product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Recombinant Proteins, with revenue, gross margin and global market share of Recombinant Proteins from 2018 to 2023.
Chapter 3, the Recombinant Proteins competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Recombinant Proteins market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Recombinant Proteins.
Chapter 13, to describe Recombinant Proteins research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Recombinant Proteins
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Recombinant Proteins by Type
1.3.1 Overview: Global Recombinant Proteins Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Recombinant Proteins Consumption Value Market Share by Type in 2022
1.3.3 Hormones
1.3.4 Growth Factors
1.3.5 Cytokines
1.3.6 Plasma Protein Factor
1.3.7 Recombinant Metabolic Enzymes
1.3.8 Immune Checkpoint Regulators
1.3.9 Others
1.4 Global Recombinant Proteins Market by Application
1.4.1 Overview: Global Recombinant Proteins Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Biopharmaceutical Companies
1.4.3 Academic and Research Institutes
1.4.4 Contract Research Organizations
1.5 Global Recombinant Proteins Market Size & Forecast
1.6 Global Recombinant Proteins Market Size and Forecast by Region
1.6.1 Global Recombinant Proteins Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Recombinant Proteins Market Size by Region, (2018-2029)
1.6.3 North America Recombinant Proteins Market Size and Prospect (2018-2029)
1.6.4 Europe Recombinant Proteins Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Recombinant Proteins Market Size and Prospect (2018-2029)
1.6.6 South America Recombinant Proteins Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Recombinant Proteins Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Abcam PLC
2.1.1 Abcam PLC Details
2.1.2 Abcam PLC Major Business
2.1.3 Abcam PLC Recombinant Proteins Product and Solutions
2.1.4 Abcam PLC Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abcam PLC Recent Developments and Future Plans
2.2 R&D Systems
2.2.1 R&D Systems Details
2.2.2 R&D Systems Major Business
2.2.3 R&D Systems Recombinant Proteins Product and Solutions
2.2.4 R&D Systems Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 R&D Systems Recent Developments and Future Plans
2.3 Miltenyi Biotec
2.3.1 Miltenyi Biotec Details
2.3.2 Miltenyi Biotec Major Business
2.3.3 Miltenyi Biotec Recombinant Proteins Product and Solutions
2.3.4 Miltenyi Biotec Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Miltenyi Biotec Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Recombinant Proteins Product and Solutions
2.4.4 Thermo Fisher Scientific Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Sigma Aldrich Company
2.5.1 Sigma Aldrich Company Details
2.5.2 Sigma Aldrich Company Major Business
2.5.3 Sigma Aldrich Company Recombinant Proteins Product and Solutions
2.5.4 Sigma Aldrich Company Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sigma Aldrich Company Recent Developments and Future Plans
2.6 GE Healthcare
2.6.1 GE Healthcare Details
2.6.2 GE Healthcare Major Business
2.6.3 GE Healthcare Recombinant Proteins Product and Solutions
2.6.4 GE Healthcare Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 GE Healthcare Recent Developments and Future Plans
2.7 Lonza
2.7.1 Lonza Details
2.7.2 Lonza Major Business
2.7.3 Lonza Recombinant Proteins Product and Solutions
2.7.4 Lonza Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Lonza Recent Developments and Future Plans
2.8 Merck KGaA
2.8.1 Merck KGaA Details
2.8.2 Merck KGaA Major Business
2.8.3 Merck KGaA Recombinant Proteins Product and Solutions
2.8.4 Merck KGaA Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Merck KGaA Recent Developments and Future Plans
2.9 ProSpec Tany TechnoGene
2.9.1 ProSpec Tany TechnoGene Details
2.9.2 ProSpec Tany TechnoGene Major Business
2.9.3 ProSpec Tany TechnoGene Recombinant Proteins Product and Solutions
2.9.4 ProSpec Tany TechnoGene Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 ProSpec Tany TechnoGene Recent Developments and Future Plans
2.10 Eurogentec (Kaneka Corporation)
2.10.1 Eurogentec (Kaneka Corporation) Details
2.10.2 Eurogentec (Kaneka Corporation) Major Business
2.10.3 Eurogentec (Kaneka Corporation) Recombinant Proteins Product and Solutions
2.10.4 Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Eurogentec (Kaneka Corporation) Recent Developments and Future Plans
2.11 PeproTech
2.11.1 PeproTech Details
2.11.2 PeproTech Major Business
2.11.3 PeproTech Recombinant Proteins Product and Solutions
2.11.4 PeproTech Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 PeproTech Recent Developments and Future Plans
2.12 BPS Bioscience
2.12.1 BPS Bioscience Details
2.12.2 BPS Bioscience Major Business
2.12.3 BPS Bioscience Recombinant Proteins Product and Solutions
2.12.4 BPS Bioscience Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 BPS Bioscience Recent Developments and Future Plans
2.13 Reprocell
2.13.1 Reprocell Details
2.13.2 Reprocell Major Business
2.13.3 Reprocell Recombinant Proteins Product and Solutions
2.13.4 Reprocell Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Reprocell Recent Developments and Future Plans
2.14 GenScript Biotech Corporation
2.14.1 GenScript Biotech Corporation Details
2.14.2 GenScript Biotech Corporation Major Business
2.14.3 GenScript Biotech Corporation Recombinant Proteins Product and Solutions
2.14.4 GenScript Biotech Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 GenScript Biotech Corporation Recent Developments and Future Plans
2.15 Abnova Corporation
2.15.1 Abnova Corporation Details
2.15.2 Abnova Corporation Major Business
2.15.3 Abnova Corporation Recombinant Proteins Product and Solutions
2.15.4 Abnova Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Abnova Corporation Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Recombinant Proteins Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Recombinant Proteins by Company Revenue
3.2.2 Top 3 Recombinant Proteins Players Market Share in 2022
3.2.3 Top 6 Recombinant Proteins Players Market Share in 2022
3.3 Recombinant Proteins Market: Overall Company Footprint Analysis
3.3.1 Recombinant Proteins Market: Region Footprint
3.3.2 Recombinant Proteins Market: Company Product Type Footprint
3.3.3 Recombinant Proteins Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Recombinant Proteins Consumption Value and Market Share by Type (2018-2023)
4.2 Global Recombinant Proteins Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Recombinant Proteins Consumption Value Market Share by Application (2018-2023)
5.2 Global Recombinant Proteins Market Forecast by Application (2024-2029)
6 North America
6.1 North America Recombinant Proteins Consumption Value by Type (2018-2029)
6.2 North America Recombinant Proteins Consumption Value by Application (2018-2029)
6.3 North America Recombinant Proteins Market Size by Country
6.3.1 North America Recombinant Proteins Consumption Value by Country (2018-2029)
6.3.2 United States Recombinant Proteins Market Size and Forecast (2018-2029)
6.3.3 Canada Recombinant Proteins Market Size and Forecast (2018-2029)
6.3.4 Mexico Recombinant Proteins Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Recombinant Proteins Consumption Value by Type (2018-2029)
7.2 Europe Recombinant Proteins Consumption Value by Application (2018-2029)
7.3 Europe Recombinant Proteins Market Size by Country
7.3.1 Europe Recombinant Proteins Consumption Value by Country (2018-2029)
7.3.2 Germany Recombinant Proteins Market Size and Forecast (2018-2029)
7.3.3 France Recombinant Proteins Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Recombinant Proteins Market Size and Forecast (2018-2029)
7.3.5 Russia Recombinant Proteins Market Size and Forecast (2018-2029)
7.3.6 Italy Recombinant Proteins Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Proteins Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Recombinant Proteins Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Recombinant Proteins Market Size by Region
8.3.1 Asia-Pacific Recombinant Proteins Consumption Value by Region (2018-2029)
8.3.2 China Recombinant Proteins Market Size and Forecast (2018-2029)
8.3.3 Japan Recombinant Proteins Market Size and Forecast (2018-2029)
8.3.4 South Korea Recombinant Proteins Market Size and Forecast (2018-2029)
8.3.5 India Recombinant Proteins Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Recombinant Proteins Market Size and Forecast (2018-2029)
8.3.7 Australia Recombinant Proteins Market Size and Forecast (2018-2029)
9 South America
9.1 South America Recombinant Proteins Consumption Value by Type (2018-2029)
9.2 South America Recombinant Proteins Consumption Value by Application (2018-2029)
9.3 South America Recombinant Proteins Market Size by Country
9.3.1 South America Recombinant Proteins Consumption Value by Country (2018-2029)
9.3.2 Brazil Recombinant Proteins Market Size and Forecast (2018-2029)
9.3.3 Argentina Recombinant Proteins Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Proteins Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Recombinant Proteins Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Recombinant Proteins Market Size by Country
10.3.1 Middle East & Africa Recombinant Proteins Consumption Value by Country (2018-2029)
10.3.2 Turkey Recombinant Proteins Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Recombinant Proteins Market Size and Forecast (2018-2029)
10.3.4 UAE Recombinant Proteins Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Recombinant Proteins Market Drivers
11.2 Recombinant Proteins Market Restraints
11.3 Recombinant Proteins Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Recombinant Proteins Industry Chain
12.2 Recombinant Proteins Upstream Analysis
12.3 Recombinant Proteins Midstream Analysis
12.4 Recombinant Proteins Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Recombinant Proteins Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Recombinant Proteins Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Recombinant Proteins Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Recombinant Proteins Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Abcam PLC Company Information, Head Office, and Major Competitors
Table 6. Abcam PLC Major Business
Table 7. Abcam PLC Recombinant Proteins Product and Solutions
Table 8. Abcam PLC Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Abcam PLC Recent Developments and Future Plans
Table 10. R&D Systems Company Information, Head Office, and Major Competitors
Table 11. R&D Systems Major Business
Table 12. R&D Systems Recombinant Proteins Product and Solutions
Table 13. R&D Systems Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. R&D Systems Recent Developments and Future Plans
Table 15. Miltenyi Biotec Company Information, Head Office, and Major Competitors
Table 16. Miltenyi Biotec Major Business
Table 17. Miltenyi Biotec Recombinant Proteins Product and Solutions
Table 18. Miltenyi Biotec Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Miltenyi Biotec Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Major Business
Table 22. Thermo Fisher Scientific Recombinant Proteins Product and Solutions
Table 23. Thermo Fisher Scientific Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Thermo Fisher Scientific Recent Developments and Future Plans
Table 25. Sigma Aldrich Company Company Information, Head Office, and Major Competitors
Table 26. Sigma Aldrich Company Major Business
Table 27. Sigma Aldrich Company Recombinant Proteins Product and Solutions
Table 28. Sigma Aldrich Company Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Sigma Aldrich Company Recent Developments and Future Plans
Table 30. GE Healthcare Company Information, Head Office, and Major Competitors
Table 31. GE Healthcare Major Business
Table 32. GE Healthcare Recombinant Proteins Product and Solutions
Table 33. GE Healthcare Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. GE Healthcare Recent Developments and Future Plans
Table 35. Lonza Company Information, Head Office, and Major Competitors
Table 36. Lonza Major Business
Table 37. Lonza Recombinant Proteins Product and Solutions
Table 38. Lonza Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Lonza Recent Developments and Future Plans
Table 40. Merck KGaA Company Information, Head Office, and Major Competitors
Table 41. Merck KGaA Major Business
Table 42. Merck KGaA Recombinant Proteins Product and Solutions
Table 43. Merck KGaA Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Merck KGaA Recent Developments and Future Plans
Table 45. ProSpec Tany TechnoGene Company Information, Head Office, and Major Competitors
Table 46. ProSpec Tany TechnoGene Major Business
Table 47. ProSpec Tany TechnoGene Recombinant Proteins Product and Solutions
Table 48. ProSpec Tany TechnoGene Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. ProSpec Tany TechnoGene Recent Developments and Future Plans
Table 50. Eurogentec (Kaneka Corporation) Company Information, Head Office, and Major Competitors
Table 51. Eurogentec (Kaneka Corporation) Major Business
Table 52. Eurogentec (Kaneka Corporation) Recombinant Proteins Product and Solutions
Table 53. Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Eurogentec (Kaneka Corporation) Recent Developments and Future Plans
Table 55. PeproTech Company Information, Head Office, and Major Competitors
Table 56. PeproTech Major Business
Table 57. PeproTech Recombinant Proteins Product and Solutions
Table 58. PeproTech Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. PeproTech Recent Developments and Future Plans
Table 60. BPS Bioscience Company Information, Head Office, and Major Competitors
Table 61. BPS Bioscience Major Business
Table 62. BPS Bioscience Recombinant Proteins Product and Solutions
Table 63. BPS Bioscience Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. BPS Bioscience Recent Developments and Future Plans
Table 65. Reprocell Company Information, Head Office, and Major Competitors
Table 66. Reprocell Major Business
Table 67. Reprocell Recombinant Proteins Product and Solutions
Table 68. Reprocell Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Reprocell Recent Developments and Future Plans
Table 70. GenScript Biotech Corporation Company Information, Head Office, and Major Competitors
Table 71. GenScript Biotech Corporation Major Business
Table 72. GenScript Biotech Corporation Recombinant Proteins Product and Solutions
Table 73. GenScript Biotech Corporation Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. GenScript Biotech Corporation Recent Developments and Future Plans
Table 75. Abnova Corporation Company Information, Head Office, and Major Competitors
Table 76. Abnova Corporation Major Business
Table 77. Abnova Corporation Recombinant Proteins Product and Solutions
Table 78. Abnova Corporation Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Abnova Corporation Recent Developments and Future Plans
Table 80. Global Recombinant Proteins Revenue (USD Million) by Players (2018-2023)
Table 81. Global Recombinant Proteins Revenue Share by Players (2018-2023)
Table 82. Breakdown of Recombinant Proteins by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Recombinant Proteins, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Recombinant Proteins Players
Table 85. Recombinant Proteins Market: Company Product Type Footprint
Table 86. Recombinant Proteins Market: Company Product Application Footprint
Table 87. Recombinant Proteins New Market Entrants and Barriers to Market Entry
Table 88. Recombinant Proteins Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Recombinant Proteins Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Recombinant Proteins Consumption Value Share by Type (2018-2023)
Table 91. Global Recombinant Proteins Consumption Value Forecast by Type (2024-2029)
Table 92. Global Recombinant Proteins Consumption Value by Application (2018-2023)
Table 93. Global Recombinant Proteins Consumption Value Forecast by Application (2024-2029)
Table 94. North America Recombinant Proteins Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Recombinant Proteins Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Recombinant Proteins Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Recombinant Proteins Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Recombinant Proteins Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Recombinant Proteins Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Recombinant Proteins Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Recombinant Proteins Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Recombinant Proteins Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Recombinant Proteins Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Recombinant Proteins Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Recombinant Proteins Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Recombinant Proteins Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Recombinant Proteins Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Recombinant Proteins Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Recombinant Proteins Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Recombinant Proteins Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Recombinant Proteins Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Recombinant Proteins Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Recombinant Proteins Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Recombinant Proteins Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Recombinant Proteins Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Recombinant Proteins Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Recombinant Proteins Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Recombinant Proteins Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Recombinant Proteins Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Recombinant Proteins Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Recombinant Proteins Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Recombinant Proteins Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Recombinant Proteins Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Recombinant Proteins Raw Material
Table 125. Key Suppliers of Recombinant Proteins Raw Materials
List of Figures
Figure 1. Recombinant Proteins Picture
Figure 2. Global Recombinant Proteins Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Recombinant Proteins Consumption Value Market Share by Type in 2022
Figure 4. Hormones
Figure 5. Growth Factors
Figure 6. Cytokines
Figure 7. Plasma Protein Factor
Figure 8. Recombinant Metabolic Enzymes
Figure 9. Immune Checkpoint Regulators
Figure 10. Others
Figure 11. Global Recombinant Proteins Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 12. Recombinant Proteins Consumption Value Market Share by Application in 2022
Figure 13. Biopharmaceutical Companies Picture
Figure 14. Academic and Research Institutes Picture
Figure 15. Contract Research Organizations Picture
Figure 16. Global Recombinant Proteins Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Recombinant Proteins Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Market Recombinant Proteins Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 19. Global Recombinant Proteins Consumption Value Market Share by Region (2018-2029)
Figure 20. Global Recombinant Proteins Consumption Value Market Share by Region in 2022
Figure 21. North America Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East and Africa Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Recombinant Proteins Revenue Share by Players in 2022
Figure 27. Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 28. Global Top 3 Players Recombinant Proteins Market Share in 2022
Figure 29. Global Top 6 Players Recombinant Proteins Market Share in 2022
Figure 30. Global Recombinant Proteins Consumption Value Share by Type (2018-2023)
Figure 31. Global Recombinant Proteins Market Share Forecast by Type (2024-2029)
Figure 32. Global Recombinant Proteins Consumption Value Share by Application (2018-2023)
Figure 33. Global Recombinant Proteins Market Share Forecast by Application (2024-2029)
Figure 34. North America Recombinant Proteins Consumption Value Market Share by Type (2018-2029)
Figure 35. North America Recombinant Proteins Consumption Value Market Share by Application (2018-2029)
Figure 36. North America Recombinant Proteins Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 38. Canada Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 39. Mexico Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 40. Europe Recombinant Proteins Consumption Value Market Share by Type (2018-2029)
Figure 41. Europe Recombinant Proteins Consumption Value Market Share by Application (2018-2029)
Figure 42. Europe Recombinant Proteins Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 44. France Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 45. United Kingdom Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 46. Russia Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 47. Italy Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Recombinant Proteins Consumption Value Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Recombinant Proteins Consumption Value Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Recombinant Proteins Consumption Value Market Share by Region (2018-2029)
Figure 51. China Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 52. Japan Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 53. South Korea Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 54. India Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 55. Southeast Asia Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 56. Australia Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 57. South America Recombinant Proteins Consumption Value Market Share by Type (2018-2029)
Figure 58. South America Recombinant Proteins Consumption Value Market Share by Application (2018-2029)
Figure 59. South America Recombinant Proteins Consumption Value Market Share by Country (2018-2029)
Figure 60. Brazil Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 61. Argentina Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 62. Middle East and Africa Recombinant Proteins Consumption Value Market Share by Type (2018-2029)
Figure 63. Middle East and Africa Recombinant Proteins Consumption Value Market Share by Application (2018-2029)
Figure 64. Middle East and Africa Recombinant Proteins Consumption Value Market Share by Country (2018-2029)
Figure 65. Turkey Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 66. Saudi Arabia Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 67. UAE Recombinant Proteins Consumption Value (2018-2029) & (USD Million)
Figure 68. Recombinant Proteins Market Drivers
Figure 69. Recombinant Proteins Market Restraints
Figure 70. Recombinant Proteins Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Recombinant Proteins in 2022
Figure 73. Manufacturing Process Analysis of Recombinant Proteins
Figure 74. Recombinant Proteins Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
